Tag archives: Ernst and Young

Building the health systems of tomorrow: dealmaking and the future of the life sciences sector

By Troy Ungerman (Toronto) on April 23, 2019 Posted in M&A, Pharmaceuticals and life sciences

EY has recently published a year-in-review report for deal making in the global life sciences industry. The publication features some interesting statistics about deal activity in the past year, and makes predictions about which trends will carry forward into the 2019 and beyond. The total value of life sciences deals in 2018 was US $198 … Continue reading

Asset and wealth management M&A activities in 2018 and beyond

By Troy Ungerman (Toronto) on February 28, 2019 Posted in M&A

Merger and acquisition activities in 2018 in the asset and wealth management sector logged a total of 140 deals, up 5% from last year. According to an overview published by PwC, the total announced value of the M&A deals was US$14.9 billion, which represented a year-over-year increase up 72% – the highest percentage increase since … Continue reading

Canadian M&A market still thought to be strong despite recent cut backs

By Troy Ungerman (Toronto) on December 6, 2018 Posted in M&A

Despite some cut backs in M&A activity expected over the next 12 months, the results reported in Ernst & Young’s (E&Y) 19th edition of the Global Capital Confidence Barometer (the “Report”) make clear that Canadian executives remain optimistic about Canadian and global M&A markets. Canadian executives are traditionally thought to be very bullish on the Canadian and global economy, and it … Continue reading

Q1 2018 review: record deal values for the power and utilities sector

By Troy Ungerman (Toronto) on July 25, 2018 Posted in Energy, Infrastructure, mining and commodities

A recent report by Ernst & Young (the Report) has concluded that the power and utilities (P&U) is thriving, as global deal value in the first quarter of 2018 reached an all-time high of US$97 billion. This rise has predominately been driven by mega-deals, with only 15 deals forming 90% of the total global deal value in the … Continue reading

A healthy dose of deal-making: M&A trends in the US and Canadian healthcare sector

By Troy Ungerman (Toronto) on May 3, 2018 Posted in M&A, Pharmaceuticals and life sciences

In the first quarter of 2018, M&A activity across the world hit a 17 year record high according to Mergermarket’s Q1 2018 Global M&A Report. This is an 18 percent increase in value compared to the first quarter of 2017. This increase was affected by the surge in deal-making seen at the end of 2017 … Continue reading

M&A update in the global technology industry for Q1 2016

By Troy Ungerman (Toronto) on July 13, 2016 Posted in Technology and innovation

According to a report recently published by Ernst &Young (EY) entitled “Global technology M&A report: 1Q16 final look – Digital disruption, slow organic growth drive tech deals”, mergers & acquisitions in the global technology industry remained strong in Q1 2016, despite macroeconomic uncertainty particularly in the equity and debt markets. Interestingly, the deal volume in … Continue reading

What can companies learn from PE sharks?

By Jacob Cawker (Toronto) on April 20, 2016 Posted in Corporate finance, Financial institutions, Pharmaceuticals and life sciences, Technology and innovation

Divestment is one strategy that a corporation can use to unlock funds for future growth and create long‑term shareholder value. According to a recent E&Y study, a successful divestment must meet three criteria: (i) it must create a positive impact on the valuation multiple of the remaining company; (ii) it must generate a sale price … Continue reading

Global M&A appetite: executives continue to be hungry

By Kassy Corothers (Calgary) on December 8, 2015 Posted in Corporate finance

Executives around the world have a strong appetite to pursue acquisitions, the highest in six years, according to Ernst & Young’s Global Capital Confidence Barometer (the Report), released at the end of October. The bi-annual Report details how despite market volatility, companies have confidence in deal-making and are pursuing growth opportunities and acquisitions at increasingly … Continue reading

Canadian Mining Eye Index looking up in Q2

By Kassy Corothers (Calgary) on September 15, 2015 Posted in Corporate finance, Infrastructure, mining and commodities

According to an Ernst and Young report released on August 24, 2015, the Canadian Mining Eye index experienced a 4% gain in Q2 2015, as compared to a 1% loss in Q1 2015. This increase was the first quarterly gain for the index since Q2 2014. While the quarterly results in the sector reported by … Continue reading

M&A in Canada: industry revenue and profits

By Bruce Sheiner on July 7, 2015 Posted in Corporate finance, Finance, Infrastructure, mining and commodities, Pharmaceuticals and life sciences, Transport

Expanding growth in nearly all sectors Norton Rose Fulbright focuses its services on 6 key industry sectors and, according to a study released recently by the Globe and Mail on Canadian corporations, almost all of these sectors have seen an expansion in revenue and most have seen growth in profits during the period from 2011 to … Continue reading